Advanced Biomed Inc
Research Advanced Biomed Inc (ADVB) on Bullrun: market cap USD 15.00M, P/E 57.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerADVB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 15.00M
- P/E57.7
- Financial periodQ1 2026
- RevenueUSD 0
- Net incomeUSD 5.28M
- Free cash flow-USD 241.04K
Valuation Snapshot
latest market cap is USD 15.00M; P/E is 57.7.
Peer valuation comparison
Latest P/E is 57.66x versus a Healthcare sector median of 24.46x (135.7% above).
Latest P/E is 57.66x versus a United States median of 24.87x (131.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | -USD 3.26M | -USD 5.86M | n/a | -0.16 | USD 2.87M | USD 21.09K | USD 3.48M |
| FY2024 | USD 0 | -USD 2.78M | -USD 2.20M | n/a | -0.14 | USD 2.61M | USD 290.03K | USD 1.66M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 15.00M | 57.7 | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.32M | 44.9 | n/a | n/a |
About Advanced Biomed Inc
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Advanced Biomed Inc's market cap?
Advanced Biomed Inc's market capitalization is USD 15.00M.
What is Advanced Biomed Inc's P/E ratio?
Advanced Biomed Inc's price-to-earnings (P/E) ratio is 57.7.
What does Advanced Biomed Inc do?
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.